Blockchain Registration Transaction Record

Nutriband Chairman to Present at Emerging Growth Conference Oct 2025

Nutriband Chairman presents at Noble Capital Markets conference Oct 2025. Learn about their abuse-deterrent fentanyl patch technology and investment opportunities in transdermal pharmaceuticals.

This announcement matters because it represents a critical opportunity for investors and healthcare stakeholders to understand Nutriband's innovative approach to addressing the opioid crisis through their AVERSA™ abuse-deterrent technology. With opioid abuse remaining a significant public health crisis globally, technologies that can prevent misuse of potent pain medications like fentanyl could substantially reduce overdose deaths and addiction rates. For investors, this presentation offers insight into a company developing solutions for a multi-billion dollar market while addressing a pressing social issue. The timing is particularly relevant as regulatory agencies increasingly prioritize abuse-deterrent formulations, potentially creating significant market advantages for companies with validated technologies. For healthcare providers and patients, successful development of such technologies could mean safer pain management options and reduced risks of accidental exposure or intentional misuse.